CYP4A11 is repressed by retinoic acid in human liver cells

Joseph Antoun1, Yolande Amet, Brigitte Simon

  • 1EA-948 Laboratoire de Biochimie, Faculté de Médecine et des Sciences de la Santé, CS 93837, Brest, France.

FEBS Letters
|May 23, 2006
PubMed

Insights

Retinoids significantly decrease CYP4A11 expression and activity in human liver cells. This suppression of cytochrome P450 4A11 (CYP4A11) impacts lipid metabolism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hepatology

Background:

  • Cytochrome P450 4A11 (CYP4A11) is a key enzyme in human liver fatty acid metabolism.
  • The precise roles and regulatory mechanisms of CYP4A11 remain largely unelucidated.
  • Understanding CYP4A11 regulation is crucial for comprehending lipid homeostasis.

Purpose of the Study:

  • To investigate the impact of retinoids on CYP4A11 regulation in human liver cells.
  • To determine how all-trans-retinoic acid affects CYP4A11 gene expression, protein levels, and enzymatic activity.

Main Methods:

  • Utilized the human hepatoma cell line HepaRG for experimental studies.
  • Administered all-trans-retinoic acid to HepaRG cells.
  • Quantified CYP4A11 gene expression and apoprotein levels.
  • Assessed microsomal lauric acid hydroxylation activity as a measure of CYP4A11 function.

Main Results:

  • All-trans-retinoic acid treatment led to a significant reduction in CYP4A11 gene expression.
  • A decrease in CYP4A11 apoprotein content was observed following retinoid exposure.
  • Microsomal lauric acid hydroxylation activity was reduced by approximately 50%.

Conclusions:

  • Retinoids strongly suppress CYP4A11 expression and activity in human liver cells.
  • This retinoid-mediated downregulation of CYP4A11 may significantly influence hepatic fatty acid metabolism.
  • Further research is warranted to explore the clinical implications of this regulatory pathway.